Condition: Opioid Use Disorder · Injection Related Infections · Stimulant Use Disorder · Sponsor: Elana Rosenthal
This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.
This description comes directly from the study's public registry record.
Rachel Silk · 301-326-7652 · rsilk@ihv.umaryland.edu
Always discuss trial participation with your own doctor first.
| George Washington University | Washington D.C., District of Columbia, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| University of Maryland Baltimore | Baltimore, Maryland, United States | Recruiting |
| West Virginia University | Morgantown, West Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06513156